Crucially, the promotion of tumor antigen processing and presentation by zebularine is dependent on NF-κB and type I interferon signaling, which ultimately affects the infiltration of T cells into the TME for killing and inhibition of tumor growth. Here, NFKB1 is linked to neoplasm.